| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Mar 5, 2025 | Editas Medicine, Inc. | CFO | Sell | 47.5 | -4,109 | -3.52% | ✗ | $7K |
| Aug 14, 2024 | Aug 15, 2024 | Beyond Air, Inc. | Director | Buy | 91.3 | +39,266 | 904.33% | ✗ | $15.6K |
| May 20, 2024 | May 22, 2024 | Editas Medicine, Inc. | CFO | Sell | 42.5 | -22,337 | -16.05% | ✗ | $125.4K |
| Mar 16, 2023 | Mar 20, 2023 | Beyond Air, Inc. | Director | Buy | 91.3 | +2,000 | 85.40% | ✗ | $13.6K |